Clinical Trials Directory

Trials / Completed

CompletedNCT04967599

Alcohol Metabolism and Disease Risk in Asians

Alcohol Metabolism and Disease Risk in Asians: Examining the Impact of Personalized Phenotypic/Genotypic Feedback and Motivational Processes on Early Drinking Trajectories

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
360 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
All
Age
17 Years – 25 Years
Healthy volunteers
Accepted

Summary

The primary pathway of alcohol metabolism involves two main enzymes, alcohol and aldehyde dehydrogenase. Several genes that encode these enzymes have variants that alter the rate of alcohol metabolism and increase levels of acetaldehyde. The variant ALDH2\*2 allele is associated with the flushing response (i.e., Asian glow) and is found almost exclusively in individuals of east Asian descent. Although having variant ALDH2 alleles is protective against heavy drinking and alcohol use disorders, for those who do drink, these variants also are associated with elevations in risk for several health problems. The premise of this study is that we can affect early drinking behavior through personalized communication about these health-related risks.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPhenotype Feedback InterventionOnline session providing information on health-related risk associated with alcohol consumption and alcohol metabolism gene variations plus personalized feedback on flushing phenotype and associated risks.
BEHAVIORALGenotype Feedback InterventionOnline session providing personalized feedback on alcohol metabolism genotypes and associated health-related risks.

Timeline

Start date
2021-08-18
Primary completion
2023-01-18
Completion
2023-01-18
First posted
2021-07-19
Last updated
2024-12-24
Results posted
2024-12-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04967599. Inclusion in this directory is not an endorsement.